Results 91 to 100 of about 24,654 (177)

Is There an Entity of Chemically Induced BCR-ABL–Positive Chronic Myelogenous Leukemia?

open access: yesThe Oncologist, 2008
Abstract Learning Objectives After completing this course, the reader will be able to: Distinguish the exogenous causes of acute and chronic myelogenous leukemia.Discuss the evidence establishing the exogenous causes of secondary leukemia.Describe the relationship of radiation and chemical exposure to
openaire   +2 more sources

Ponatinib active in BCR–ABL-positive disease [PDF]

open access: yesNature Reviews Clinical Oncology, 2013
openaire   +1 more source

From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents

open access: yesEJC Paediatric Oncology
This review aims to discuss similarities and dissimilarities between BCR::ABL1-rearranged (Philadelphia chromosome-positive [Ph+]) and ABL-class fusion-driven BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL) in children and adolescents. Recent
Sarah K. Tasian   +2 more
doaj   +1 more source

The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients

open access: yesHaematologica, 2004
Using quantitative reverse-transcription polymerase chain reaction we investigated the significance of achieving molecular complete remission (CR) in 12 patients with bcr/abl-positive acute lymphocytic leukemia treated with imatinib.
PP Piccaluga   +9 more
doaj  

Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL Positive Acute Lymphoblstic Leukemia. [PDF]

open access: yesIndian J Hematol Blood Transfus, 2019
Agrawal N   +7 more
europepmc   +1 more source

Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. [PDF]

open access: yesHaematologica, 2022
Kayser S   +13 more
europepmc   +1 more source

Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia. [PDF]

open access: yesCancer Res
Luo Z   +15 more
europepmc   +1 more source

Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study. [PDF]

open access: yesCancer Med, 2019
Foulon S   +7 more
europepmc   +1 more source

Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. [PDF]

open access: yesMediterr J Hematol Infect Dis
Paciaroni K   +8 more
europepmc   +1 more source

BCR-ABL Positive Childhood Chronic Myeloid Leukemia

open access: yesJournal of Case Reports, 2017
Timothy A. Ekwere, Emmanuel K. Abudu
openaire   +2 more sources

Home - About - Disclaimer - Privacy